These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Value of corticoid therapy in flexion spasms (infantile myoclonic encephalopathy with hypsarrhythmia)]. Popescu V; Stamate M; Arion C Rev Pediatr Obstet Ginecol Pediatr; 1975; 24(2):173-80. PubMed ID: 171714 [No Abstract] [Full Text] [Related]
24. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy]. Lhermitte F; Degos CF; Marteau R Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935 [No Abstract] [Full Text] [Related]
25. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
26. Steroid-dependent form of Kinsbourne syndrome: successful treatment with trazodone. Papini M; Pasquinelli A; Filippini A Ital J Neurol Sci; 1992 May; 13(4):369-72. PubMed ID: 1318289 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Gascon G; Wallenberg B; Daif AK; Ozand P Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864 [TBL] [Abstract][Full Text] [Related]
28. Biochemistry and therapeutics of posthypoxic myoclonus. Van Woert MH; Rosenbaum D; Chung EY Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644 [No Abstract] [Full Text] [Related]
29. Serotonin models of myoclonus in the guinea pig and rat. Wolfson LI; Thal LJ; Brown LL Adv Neurol; 1986; 43():519-27. PubMed ID: 3484858 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT. Jenner P; Pratt JA; Marsden CD Adv Neurol; 1986; 43():629-43. PubMed ID: 2418652 [TBL] [Abstract][Full Text] [Related]
31. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431 [TBL] [Abstract][Full Text] [Related]
32. The pharmacology of myoclonus. Pranzatelli MR; Snodgrass SR Clin Neuropharmacol; 1985; 8(2):99-130. PubMed ID: 2988772 [No Abstract] [Full Text] [Related]
34. Letter: Myoclonic encephalopathy and neuroblastoma. Delalieux C; Ebinger C; Maurus R; Sliwowski H N Engl J Med; 1975 Jan; 292(1):46-7. PubMed ID: 1109191 [No Abstract] [Full Text] [Related]
35. Manipulation of brain serotonin in the treatment of myoclonus. Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240 [TBL] [Abstract][Full Text] [Related]
36. Fluoxetine in the treatment of intention myoclonus. Van Woert MH; Magnussen I; Rosenbaum D; Chung E Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599 [TBL] [Abstract][Full Text] [Related]
37. Myoclonus. Marsden CD Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145 [No Abstract] [Full Text] [Related]
38. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan. Pranzatelli MR; Tate E; Huang Y; Haas RH; Bodensteiner J; Ashwal S; Franz D Epilepsia; 1995 Aug; 36(8):783-91. PubMed ID: 7543407 [TBL] [Abstract][Full Text] [Related]
39. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
40. p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus. Pratt JA; Rothwell J; Jenner P; Marsden CD Adv Neurol; 1986; 43():577-88. PubMed ID: 2418651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]